ANEBULO PHARMACEUTICALS, INC. Investment Income, Net
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Investment Income, Net of $68.08 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2024-05-15
- ANEBULO PHARMACEUTICALS, INC. investment income, net for the quarter ending 2024-03-31 was $68.08K, a 13.98% decline year-over-year.
- ANEBULO PHARMACEUTICALS, INC. investment income, net for the quarter ending 2023-12-31 was $75.52K, a 756.65% increase year-over-year.
- ANEBULO PHARMACEUTICALS, INC. investment income, net for the quarter ending 2023-03-31 was $79.15K.
- ANEBULO PHARMACEUTICALS, INC. investment income, net for the quarter ending 2022-12-31 was $8.82K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2024-03-31 | $68.08K 10-Q · filed 2024-05-15 | $143.61K derived: sum of 2 quarters · filed 2024-05-15 | $198.80K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $75.52K 10-Q · filed 2024-02-13 | $130.72K 10-Q · filed 2024-02-13 | |
| 2023-03-31 | $79.15K 10-Q · filed 2024-05-15 | $87.97K derived: sum of 2 quarters · filed 2024-05-15 | $92.40K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $8.82K 10-Q · filed 2024-02-13 | $13.25K 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |